ACM
PFE icon

Anfield Capital Management’s Pfizer PFE Stock Holding History

Anfield Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.4K Buy
2,543
+1,692
+199% +$45K 0.02% 213
2025
Q4 		$21.2K Buy
851
+487
+134% +$12.3K 0.01% 256
2025
Q3 		$9.26K Buy
364
+17
+5% +$420 ﹤0.01% 341
2025
Q2 		$8.4K Hold
347
– – ﹤0.01% 317
2025
Q1 		$8.78K Buy
347
+1
+0.3% +$26 ﹤0.01% 252
2024
Q4 		$9.19K Hold
346
– – ﹤0.01% 247
2024
Q3 		$10K Hold
346
– – ﹤0.01% 234
2024
Q2 		$9.67K Buy
+346
New +$9.53K ﹤0.01% 195
2021
Q4 		– Sell
-280
Closed -$12K – 125
2021
Q3 		$12K Buy
+280
New +$12.4K ﹤0.01% 92
2020
Q1 		– Sell
-5,557
Closed -$201K – 303
2019
Q4 		$201K Buy
+5,557
New +$198K 0.08% 122

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Anfield Capital Management's PFE Position: Q1 2026 in Review

Anfield Capital Management increased its Pfizer (PFE) stake by 199% in Q1 2026, buying an estimated $45K and bringing the position to 2,543 shares worth $71.4K. The position accounts for 0.02% of the portfolio, ranked #213.

Anfield Capital Management first reported a position in PFE in Q4 2019 and has held it in 10 quarters since. The position peaked at $201K in Q4 2019. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Anfield Capital Management held 2,543 shares of Pfizer worth $71.4K as of Q1 2026.
  • Anfield Capital Management bought 1,692 Pfizer shares in Q1 2026, an estimated $45K.
  • Pfizer made up 0.02% of Anfield Capital Management's portfolio in Q1 2026, its #213 holding.
  • Anfield Capital Management first reported a position in Pfizer in Q4 2019 and has held it in 10 quarters since.
  • Anfield Capital Management's Pfizer position peaked at $201K in Q4 2019.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.